THE STACK
Dual chamber cartridge production — the Panacea line from synthesis to the seal
Hardware, software, and what each technology achieves — the relay of custody in one line: fill → freeze → dry → charge → close → seal. The SealoPrester owns the last step; this map is everything that hands the cartridge to it and everything the cartridge becomes afterwards. Stages are the physical production-line order; the intelligence layer spans all of them.
Intelligence layer — spans the whole line
| NAME | KIND | ACHIEVES |
|---|---|---|
| Dicoias Ψ ↗ | software — formulation intelligence | The substance/formulation knowledge engine — structure→property space, recipe governance, the design brain upstream of every run. |
| S3Pulse™ ↗ | software — control brain, all hardware | 16 relay channels, three dipped product probes as authority, Cryo-Triad event detection, Kv-learning adaptive ramp — the platform that enables every other technology. Watches every process below. |
Stage 1 — Synthesis (the molecule)
| NAME | KIND | ACHIEVES |
|---|---|---|
| Syntheseract™ ↗ | hardware — synthesizer | Continuous-flow peptide synthesis — fast, economical, observed: 64 positions, 128+ addresses, a Digital Batch DNA per run. Batch synthesis is more product, blindly; Syntheseract is scalable production, observed. |
| CFSPPS™ ↗ | technology — method category | Continuous-flow solid-phase peptide synthesis as its own discipline: in flow, every residue addition is observed and repeatable instead of assumed (setpoint ≠ experience). |
Stage 2 — Formulation (the recipe)
| NAME | KIND | ACHIEVES |
|---|---|---|
| Peptidic Liquid ↗ | the formulation itself | A peptide is only as good as the liquid it lives in. The peptide + its protective excipients (buffers, cryoprotectants, lyoprotectants, scaffolders) in solution — designed with Dicoias Ψ, defended across every phase by RF Tunnel, OxyDeplete, ArgonLock, Cryolapse, TgShift. |
| Peptourbillon™ ↗ | technology — formulation architecture | Layered peptide architecture — single- or multi-layer, never a blend. Each active keeps its own lyophilised phase; chemistries that would destroy each other in a blend arrive as neighbours, not mixtures. |
| P-EARLs™ ↗ | technology — reconstitution liquids | Panacea-Engineered Aseptic Reconstitution Liquid(s) — each tuned to the peptide it wakes (pI-aggregation behaviour, Met/Cys/His/Trp oxidation profile). Bacteriostatic water is a fine diluent and nothing more. |
| Cryoviscous™ ↗ | technology — conditioning state | The characterised cold, high-viscosity, low-mobility state — holds the formulation still for precision filling, recovers within acceptance on controlled warming. |
| OxyDeplete™ ↗ | technology — doctrine | Degassing + no-headspace: trapped oxygen does not escape, it reacts — remove it first and stability extends into years instead of months. |
| RedoxVault™ ↗ | technology — redox isolation | Separation, not suppression: redox-active catalysts (ppb iron) isolated in lipid micro-reservoirs; depot and delayed-release microsphere formats on top. |
Stage 3 — Filling (cartridge preparation)
| NAME | KIND | ACHIEVES |
|---|---|---|
| PleniDose™ ↗ | hardware — gantry | The shared filling gantry for BOTH lines (Lyoprester dual-chamber + Liquiprester liquid). Fixed rear-plunger datum; interchangeable rod-holder sets the format. Fills the peptidic liquid; later (post-lyo) inserts middle plungers and aliquots P-EARLs. The glass may vary — the dose must not. |
| ElimiVoid™ ↗ | technology — completion operation | Front-void elimination without moving the rear plunger or disturbing the API aliquot — slow top-up, fast meniscus drawback. No air bubble survives in the liquid chamber. |
| IncreSure™ ↗ | technology — dose metrology | Verified API per pen increment — characterises seven real pen parameters instead of trusting the printed dial figure. |
Stage 4 — Freezing (inside Lyochrysalis)
| NAME | KIND | ACHIEVES |
|---|---|---|
| Lyochrysalis™ ↗ | hardware — the chamber | The integrated chamber housing the whole drying stack — freezing, sublimation, desorption, and (as VANA) vacuum capping. It finishes cold — it never cooks the peptide. |
| RF Tunnel™ ↗ | technology | The RF-formed central channel through the frozen cake — two wetting fronts instead of one; reconstitution solved by geometry, not surfactants. |
Stage 5 — Drying (inside Lyochrysalis)
| NAME | KIND | ACHIEVES |
|---|---|---|
| LyoLevit™ ↗ | technology | The cake levitates and spins in high orbit (ultrasound + RF): zero-contact processing, 4–6× sublimation surface, 89% energy reduction, 99% reproducibility. |
| TgShift™ ↗ | technology | RAISES the cake’s glass-transition temperature with RF instead of chilling below it — drying runs warmer and faster while structure stays below collapse; cycles shorten from days toward hours. |
| Cryolapse™ ↗ | technology + machine | Cryogenic pressure collapse: cryopumping to −110 °C pulls cycles ~13 h → ~4 h, surfactant-free. The same machine enables ElimiVoid, IncreSure, Cryoviscous. |
| Cold finish | process doctrine | Desorption finishes at −5 °C → −3 °C. Never +40/+50 °C as others do — binding affinity and bioavailability survive. |
Stage 6 — Vacuum + inert closure (VANA mode of the Lyochrysalis chamber)
VANA is incorporated in the Lyochrysalis — the same vacuum chamber, active when used for capping/top-plungering. Cartridges enter with cake + P-EARLs fitted, WITHOUT top plunger and cap.
| NAME | KIND | ACHIEVES |
|---|---|---|
| Vana Machine™ ↗ | hardware — chamber mode | Vacuum to JUST-BEFORE-BOILING (the liquid never boils), then places the top plunger and cap under vacuum/argon — the Lyoprester becomes a closed system inside the chamber. Prevents air gaps and plunger drift; lands the target vacuum and keeps it. |
| ArgonLock™ ↗ | technology | The argon backfill: argon partially replaces the vacuum and DISSOLVES into both P-EARLs and cake — dissolved O₂ displaced, oxidation starved at the molecular level. The principle that protects welding arcs, wine cellars and the Charters of Freedom, applied to peptides. |
Stage 7 — Permanent seal
| NAME | KIND | ACHIEVES |
|---|---|---|
| SealoPrester™ | hardware — closure system | Seal o’ Precision + Sterility. The mechanical crimp of caps held until then ONLY by vacuum. Handles the ticking bomb: an extremely vacuumed, argon-charged, two-plunger cartridge where one wrong or sudden move = self-reconstitution (chambers meet early) or vacuum/argon loss. Servo capping control, vacuum cap handling, presence detection, recipe memory. The machine that in cahoots with VANA gives birth to the Lyoprester. |
Stage 8 — Product formats + packaging
| NAME | KIND | ACHIEVES |
|---|---|---|
| Lyoprester® ↗ | product format | The dual-chamber cartridge: autoreconstitution-enabled, vacuum-sealed, argon-fillback. Cake and liquid never meet until the moment of use; carries Peptourbillon loads approaching 200 mg. |
| Liquiprester™ ↗ | product format | The single-liquid cartridge: multiple peptide APIs coexist in one shared vehicle; fixed plunger datum, bore-variance self-counterbalancing, IncreSure-verified increments. |
| EZnject™ ↗ | product — device | The disposable auto-injector pen built around the Lyoprester: one twist activates autoreconstitution (P-EARLs drawn into the peptide chamber at the septa); a hundred indexed 0.1 mL doses; ships with 31G/5 mm needles and a Peptourbillon pre-loaded. |
How to read the map
Technologies are not products: Lyoprester® and Liquiprester™ are product formats the line produces, and Peptourbillons are the products the formats carry. Every other name on this page is a technology, a machine or a doctrine — the estate’s taxonomy law keeps the two lists apart.
The SealoPrester’s row is the shortest distance between the two halves of the line: everything before it builds charge into the cartridge, everything after it depends on that charge surviving. That is why the permanent seal is a stage of its own.